What does CUSIP 90400D108 represent in this 13F holders report?

CUSIP 90400D108 is the security identifier for RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK in Q1 2017?

160 institutional investors reported RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK for Q1 2017. Use the holders table for investor-level position and value details.

Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)

CUSIP: 90400D108

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class: Equity / COMMON STOCK
Shares outstanding: 98,459,627
Total 13F shares: 40,725,846
Share change: +2,216,565
Total reported value: $2,759,699,220
Put/Call ratio: 80%
Price per share: $67.78
Number of holders: 160
Value change: +$146,474,004
Number of buys: 84
Number of sells: 81

Quarterly Holders Quick Answers

What is CUSIP 90400D108?
CUSIP 90400D108 identifies RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2017
Previous quarter: Q4 2016

Recent filing periods for CUSIP 90400D108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	6%	5,882,825	$413,622,000	—	31 Dec 2016	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	5.3%	5,255,191	$369,494,000	—	31 Dec 2016	13F
Capital Research Global Investors	13F	Company	5.1%	5,004,859	$351,892,000	—	31 Dec 2016	13F
VANGUARD GROUP INC	13F	Company	2.9%	2,833,316	$199,211,000	—	31 Dec 2016	13F
BlackRock Fund Advisors	13F	Company	1.7%	1,679,460	$118,083,000	—	31 Dec 2016	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.7%	1,669,507	$117,383,000	—	31 Dec 2016	13F
STATE STREET CORP	13F	Company	1.4%	1,397,189	$98,227,000	—	31 Dec 2016	13F
COLUMBIA WANGER ASSET MANAGEMENT LLC	13F	Company	1.2%	1,175,616	$82,658,000	—	31 Dec 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.1%	1,054,386	$74,134,000	—	31 Dec 2016	13F
Capital International Investors	13F	Company	1%	1,000,854	$70,370,000	—	31 Dec 2016	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.78%	764,694	$53,766,000	—	31 Dec 2016	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.68%	668,258	$46,985,000	—	31 Dec 2016	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.64%	628,500	$44,190,000	—	31 Dec 2016	13F
CAPITAL GUARDIAN TRUST CO	13F	Company	0.58%	570,321	$40,099,000	—	31 Dec 2016	13F
NORGES BANK	13F	Company	0.53%	522,215	$36,717,000	—	31 Dec 2016	13F
JENNISON ASSOCIATES LLC	13F	Company	0.51%	500,290	$35,175,000	—	31 Dec 2016	13F
FEDERATED HERMES, INC.	13F	Company	0.45%	438,300	$30,817,000	—	31 Dec 2016	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.44%	435,716	$30,635,000	—	31 Dec 2016	13F
NORTHERN TRUST CORP	13F	Company	0.44%	428,726	$30,144,000	—	31 Dec 2016	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.41%	402,857	$28,325,000	—	31 Dec 2016	13F
FIRST TRUST ADVISORS LP	13F	Company	0.41%	401,487	$28,229,000	—	31 Dec 2016	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.39%	387,550	$27,249,000	—	31 Dec 2016	13F
ROCKEFELLER FINANCIAL SERVICES INC	13F	Company	0.39%	379,761	$26,701,000	—	31 Dec 2016	13F
OppenheimerFunds, Inc.	13F	Company	0.35%	340,215	$23,920,000	—	31 Dec 2016	13F
EMERALD ADVISERS, LLC	13F	Company	0.34%	337,629	$23,739,000	—	31 Dec 2016	13F
Polar Capital LLP	13F	Company	0.34%	331,220	$23,288,000	—	31 Dec 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.3%	298,768	$21,006,000	—	31 Dec 2016	13F
BROWN ADVISORY INC	13F	Company	0.3%	298,243	$20,970,000	—	31 Dec 2016	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.27%	264,546	$18,600,000	—	31 Dec 2016	13F
JPMORGAN CHASE & CO	13F	Company	0.26%	255,645	$17,975,000	—	31 Dec 2016	13F
AXA S.A.	13F	Company	0.24%	236,467	$16,626,000	—	31 Dec 2016	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.2%	198,821	$13,980,000	—	31 Dec 2016	13F
DEUTSCHE BANK AG\	13F	Company	0.18%	175,283	$12,320,000	—	31 Dec 2016	13F
Bank of New York Mellon Corp	13F	Company	0.18%	175,062	$12,309,000	—	31 Dec 2016	13F
ORBIMED ADVISORS LLC	13F	Company	0.17%	169,300	$11,903,000	—	31 Dec 2016	13F
WEATHERBIE CAPITAL, LLC	13F	Company	0.17%	168,915	$11,876,000	—	31 Dec 2016	13F
CAPITAL INTERNATIONAL LTD /CA/	13F	Company	0.17%	168,018	$11,813,000	—	31 Dec 2016	13F
Iguana Healthcare Management, LLC	13F	Company	0.16%	160,000	$11,250,000	—	31 Dec 2016	13F
Rock Springs Capital Management LP	13F	Company	0.16%	159,750	$11,232,000	—	31 Dec 2016	13F
TEACHERS ADVISORS, LLC	13F	Company	0.16%	158,695	$11,158,000	—	31 Dec 2016	13F
Hood River Capital Management LLC	13F	Company	0.16%	158,390	$11,136,000	—	31 Dec 2016	13F
Invesco Ltd.	13F	Company	0.16%	156,923	$11,033,000	—	31 Dec 2016	13F
ROYAL BANK OF CANADA	13F	Company	0.16%	154,804	$10,885,000	—	31 Dec 2016	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.15%	143,731	$10,106,000	—	31 Dec 2016	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.15%	143,020	$10,056,000	—	31 Dec 2016	13F
MORGAN STANLEY	13F	Company	0.14%	136,060	$9,566,000	—	31 Dec 2016	13F
BlackRock Investment Management, LLC	13F	Company	0.14%	134,979	$9,490,000	—	31 Dec 2016	13F
CITIGROUP INC	13F	Company	0.13%	128,944	$9,066,000	—	31 Dec 2016	13F
JANA PARTNERS LLC	13F	Company	0.13%	128,121	$9,008,000	—	31 Dec 2016	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.12%	118,843	$8,356,000	—	31 Dec 2016	13F

Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q1 2017

As of 31 Mar 2017, Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) was held by 160 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 40,725,846 shares. The largest 10 holders included FMR LLC, Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, COLUMBIA WANGER ASSET MANAGEMENT LLC, and CAPITAL GUARDIAN TRUST CO. This page lists 160 institutional shareholders reporting positions in this security for the Q1 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2017 vs Q4 2016 Across Filers

Q4 2016 holders

172

Q1 2017 holders

160

Holder diff

-12

Investor	Q4 2016 Shares	Q1 2017 Shares	Share Diff	Share Chg %	Q4 2016 Value $	Q1 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.